(Press-News.org) An international team of scientists and physicians used a combination of sophisticated emerging technologies and data analysis to detect 14 simple metabolites with high accuracy to predict in early pregnancy which women are at risk of developing preeclampsia in later pregnancy, according to a study reported in Hypertension: Journal of the American Heart Association. Currently there is no predictive test for the condition and no cure other than delivery of the baby.
Preeclampsia is a life-threatening condition characterized by high blood pressure and high levels of protein in the urine. The condition is thought to begin in early pregnancy with defective development of the placenta but most often does not show symptoms until the second half of pregnancy. Preeclampsia can endanger the lives of both mother and child and is a leading cause of maternal death, researchers said.
"Everything we know about this condition suggests women do not become sick and present with preeclampsia until late in pregnancy, but the condition originates in early pregnancy," said Louise C. Kenny, M.D., Ph.D., the study lead and professor of obstetrics and gynecology at the Anu Research Center, University College Cork, in Cork, Ireland. "To develop effective treatment and prevention strategies — our ultimate goal — we need to be able to start treatment in early pregnancy. We need to be able to tell who is at risk and who is not."
Researchers studied women in SCOPE (Screening for Pregnancy Endpoints), an international trial of approximately 7,000 women with first-time pregnancies which aims to predict and prevent the major diseases of late pregnancy.
In the case control study, researchers first discovered and evaluated the detection rate of the test in women at 15 weeks' gestation with low risk of preeclampsia in Auckland, New Zealand. The 60 fit, healthy, first-time pregnant women (average age 30) later developed preeclampsia. They were matched with a control group of 60 women.
The study's second phase validated the initial findings in an entirely different group of women in Adelaide, Australia. These women were younger, with an average age of 22-23 and were ethnically more diverse compared to the predominantly Caucasian group in New Zealand. Thirty-nine women subsequently developed preeclampsia later after the early test. There were 40 matched controls.
The researchers are trying to simplify the technology to develop a single blood test for the bedside that will be cheap and readily accessible to hospitals everywhere.
"In the next five years our aim is to develop a simple blood test that will be available to all pregnant women that will detect the risk of preeclampsia in early pregnancy," said Phil Baker M.D., co-investigator of the study and Dean of Medicine and Dentistry at the University of Alberta.
In the United States and in the developed world, preeclampsia affects 4 percent to 5 percent of pregnant women, but may reach 10 percent in the developing world. The World Health Organization estimates that from 100,000 to 200,000 women die each year as a direct cause of preeclampsia.
INFORMATION:
Co-authors are David I. Broadhurst, Ph.D.; Warwick Dunn, Ph.D.; Marie Brown, Ph.D.; Robyn A. North, M.D.; Lesley McCowan, M.D.; Clare Roberts, Ph.D.; Garth G. S. Cooper, Ph.D.; Douglas H. Kell, Ph.D.; and Philip N. Baker, M.D. Funding and individual author disclosures are on the manuscript.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.
NR10 – 1120 (Hypertension/Kenny)
Additional Resources:
Visit the High Blood Pressure and Women site at http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/UnderstandYourRiskforHighBloodPressure/High-Blood-Pressure-and-Women_UCM_301867_Article.jsp
Downloadable stock footage and animation are available at www.newsroom.heart.org. Click on Multimedia Resources.
New metabolic markers may predict preeclampsia in early pregnancy
American Heart Association rapid access journal report
2010-09-13
ELSE PRESS RELEASES FROM THIS DATE:
Available physician characteristics may not help patients find high-quality care
2010-09-13
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
"To improve the quality of care received by their beneficiaries, some health plans use physician report cards and tiered physician networks to steer their members toward physicians who provide high-quality care. However, most patients do not have access to ...
Diet/exercise intervention for patients at risk for heart disease improves quality of life
2010-09-13
A lifestyle intervention incorporating exercise training and diet counseling in primary health care settings appears to improve quality of life among adults at moderate to high risk for heart disease and appears cost-effective compared to standard care, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Most individuals in developed countries do not reach recommended levels of physical activity, and are thus at higher risk of illness and death, according to background information in the article. "Extensive ...
Protein-based biomarkers in blood serum could classify individuals with Alzheimer's disease
2010-09-13
An initial analysis suggests that biomarkers in blood serum can be combined with clinical information to accurately classify patients with Alzheimer's disease, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals.
"There is clearly a need for reliable and valid diagnostic and prognostic biomarkers of Alzheimer's disease, and in recent years, there has been an explosive increase of effort aimed at identifying such markers," the authors write as background information in the article. "It has been previously argued that, ...
Asthma medication may benefit patients with multiple sclerosis
2010-09-13
Adding albuterol, a compound commonly used to treat asthma and other respiratory diseases, to an existing treatment for patients with multiple sclerosis appears to improve clinical outcomes, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals.
Multiple sclerosis (MS) is a chronic inflammatory disease characterized by the degeneration of myelin, which coats nerve cells in the white matter of the central nervous system. Patients with the condition have been found to have elevated levels of interleukin-12, a biological ...
Pilot study demonstrates safety of diabetes medication for patients with Alzheimer's disease
2010-09-13
A pilot study suggests the diabetes medication pioglitazone is generally well tolerated and may warrant further study as a treatment for patients with Alzheimer's disease, according to a report posted online today that will appear in the January 2011 print issue of Archives of Neurology, one of the JAMA/Archives journals.
"Alzheimer's disease is an immense and growing public health problem," the authors write as background information in the article. "Although prescription drug therapy for the symptoms of Alzheimer's disease has been available since 1993, these agents ...
Antiviral therapy associated with fewer recurring eye problems from herpes simplex virus
2010-09-13
Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring eye-related manifestations of the disease, according to a report in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
"Herpes simplex virus (HSV) is a common cause of corneal disease and is the leading infectious cause of corneal blindness among developed nations," the authors write as background information in the article. After the initial exposure to the virus and the resulting systemic infection, ...
Repeated antibiotic use alters gut's composition of beneficial microbes, Stanford study shows
2010-09-13
STANFORD, Calif. - Repeated use of an antibiotic that is considered generally benign, because users seldom incur obvious side effects, induces cumulative and persistent changes in the composition of the beneficial microbial species inhabiting the human gut, researchers at the Stanford University School of Medicine have found.
By a conservative estimate, something like 1,000 different varieties of microbes coexist harmoniously within a typical healthy person's gut, said David Relman, MD, professor of medicine and of microbiology and immunology at the medical school and ...
Children and adults see the world differently
2010-09-13
Unlike adults, children are able to keep information from their senses separate and may therefore perceive the visual world differently, according to research published today.
Scientists at UCL (University College London) and Birkbeck, University of London have found that children younger than 12 do not combine different sensory information to make sense of the world as adults do. This does not only apply to combining different senses, such as vision and sound, but also to the different information the brain receives when looking at a scene with one eye compared to both ...
A new target in polycystic kidney disease
2010-09-13
In work suggesting a new approach to treating polycystic kidney disease (PKD), a leading cause of kidney failure, researchers at Children's Hospital Boston were able to block the formation of fluid-filled cysts, the hallmark of the disease, in a mouse model. Their findings, using a compound that inhibits a receptor known as c-Met, will be published in the September 13th online edition of the Journal of Clinical Investigation.
PKD is the most common fatal genetic disease affecting Caucasians in the U.S. Currently, there is no approved treatment to halt cyst growth, which ...
Video games lead to faster decisions that are no less accurate
2010-09-13
Cognitive scientists from the University of Rochester have discovered that playing action video games trains people to make the right decisions faster. The researchers found that video game players develop a heightened sensitivity to what is going on around them, and this benefit doesn't just make them better at playing video games, but improves a wide variety of general skills that can help with everyday activities like multitasking, driving, reading small print, keeping track of friends in a crowd, and navigating around town.
In an upcoming study in the journal Current ...
LAST 30 PRESS RELEASES:
Consistent policy, not “patchwork” regulations, recommended for the coexistence of crops
LEDs shed light on efficient tomato cultivation
2025 Ig Physics Nobel Prize for perfect pasta sauce
Bright squeezed light in the kilohertz frequency band
Water flowed on ancient asteroid
AI model offers accurate and explainable insights to support autism assessment
Process for dealing with sexual misconduct by doctors requires major reform
Severe pregnancy sickness raises risk of mental health conditions by over 50%
Early humans may have walked from Türkiye to mainland Europe, new groundbreaking research suggests
New study shows biochar’s electrical properties can influence rice field methane emissions
Guangdong faces largest chikungunya outbreak on record
Tirzepatide improves blood sugar control in children aged 10-17 years with type 2 diabetes inadequately controlled on existing therapies (SURPASS-PEDS trial)
An old drug, in a low dose, shown to be safe and effective in preventing progression of type 1 diabetes in children and young people (MELD-ATG trial)
Study reports potential effects of verapamil in slowing progression of type 1 diabetes
Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at 2-year follow-up
New estimates predict over 4 million missing people who would be alive in 2025 if not for inadequate type 1 diabetes care
So what should we call this – a grue jay?
Chicago Quantum Exchange-led coalition advances to final round in NSF Engine competition
Study identifies candidates for therapeutic targets in pediatric germ cell tumors
Media alert: The global burden of CVD
Study illuminates contributing factors to blood vessel leakage
What nations around the world can learn from Ukraine
Mixing tree species does not always make forests more drought-resilient
Public confidence in U.S. health agencies slides, fueled by declines among Democrats
“Quantum squeezing” a nanoscale particle for the first time
El Niño spurs extreme daily rain events despite drier monsoons in India
Two studies explore the genomic diversity of deadly mosquito vectors
Zebra finches categorize their vocal calls by meaning
Analysis challenges conventional wisdom about partisan support for US science funding
New model can accurately predict a forest’s future
[Press-News.org] New metabolic markers may predict preeclampsia in early pregnancyAmerican Heart Association rapid access journal report